Hayashi Shiro, Nishida Tsutomu, Shimakoshi Hiromi, Shimoda Akiyoshi, Amano Takahiro, Sugimoto Aya, Takahashi Kei, Mukai Kaori, Matsubara Tokuhiro, Yamamoto Masashi, Nakajima Sachiko, Fukui Koji, Inada Masami
Shiro Hayashi, Tsutomu Nishida, Hiromi Shimakoshi, Akiyoshi Shimoda, Takahiro Amano, Aya Sugimoto, Kei Takahashi, Kaori Mukai, Tokuhiro Matsubara, Masashi Yamamoto, Sachiko Nakajima, Koji Fukui, Masami Inada, Department of Gastroenterology and Hepatology, Toyonaka Municipal Hospital, Osaka 560-8565, Japan.
World J Gastrointest Endosc. 2016 Dec 16;8(20):777-784. doi: 10.4253/wjge.v8.i20.777.
To estimate the efficacy of 2 h post-endoscopic retrograde cholangiopancreatography (ERCP) serum amylase levels and other factors for predicting post-ERCP pancreatitis.
This was a retrospective, single-center cohort study of consecutive patients who underwent ERCP from January 2010 to December 2013. Serum amylase levels were measured 2 h post-procedure, and patient- and procedure-related pancreatitis (PEP) risk factors were analyzed using a logistic model.
A total of 1520 cases (average age 72 ± 12 years, 60% male) were initially enrolled in this study, and 1403 cases (725 patients) were ultimately analyzed after the exclusion of 117 cases. Fifty-five of these cases developed PEP. We established a 2 h serum amylase cutoff level of two times the upper limit of normal for predicting PEP. Multivariate analysis revealed that a cannulation time of more than 13 min [odds ratio (OR) 2.28, 95%CI: 1.132-4.651, = 0.0210] and 2 h amylase levels greater than the cutoff level (OR = 24.1, 95%CI: 11.56-57.13, < 0.0001) were significant predictive factors for PEP. Forty-seven of the 55 patients who developed PEP exhibited 2 h amylase levels greater than the cutoff level (85%), and six of the remaining eight patients who developed PEP (75%) required longer cannulation times. Only 2 of the 1403 patients (0.14%) who developed PEP did not exhibit concerning 2 h amylase levels or require longer cannulation times.
These findings indicate that the combination of 2 h post-ERCP serum amylase levels and cannulation times represents a valuable marker for identifying patients at high risk for PEP.
评估内镜逆行胰胆管造影术(ERCP)后2小时血清淀粉酶水平及其他因素对预测ERCP术后胰腺炎的有效性。
这是一项对2010年1月至2013年12月期间连续接受ERCP治疗的患者进行的回顾性单中心队列研究。术后2小时测量血清淀粉酶水平,并使用逻辑模型分析患者及手术相关的胰腺炎(PEP)危险因素。
本研究最初纳入1520例患者(平均年龄72±12岁,60%为男性),排除117例后,最终对1403例患者(725例)进行分析。其中55例发生PEP。我们确定预测PEP的术后2小时血清淀粉酶临界值为正常上限的两倍。多因素分析显示,插管时间超过13分钟[比值比(OR)2.28,95%置信区间:1.132 - 4.651,P = 0.0210]和术后2小时淀粉酶水平高于临界值(OR = 24.1,95%置信区间:11.56 - 57.13,P < 0.0001)是PEP的显著预测因素。发生PEP的55例患者中有47例(85%)术后2小时淀粉酶水平高于临界值,其余8例发生PEP的患者中有6例(75%)需要更长的插管时间。在发生PEP的1403例患者中,只有2例(0.14%)术后2小时淀粉酶水平无异常或不需要更长的插管时间。
这些发现表明,ERCP术后2小时血清淀粉酶水平和插管时间相结合是识别PEP高危患者的有价值指标。